GO:0016126 | sterol biosynthetic process | 30.56% (22/72) | 7.2 | 0.0 | 0.0 |
GO:0008202 | steroid metabolic process | 41.67% (30/72) | 5.45 | 0.0 | 0.0 |
GO:1901617 | organic hydroxy compound biosynthetic process | 44.44% (32/72) | 4.99 | 0.0 | 0.0 |
GO:0006694 | steroid biosynthetic process | 31.94% (23/72) | 6.46 | 0.0 | 0.0 |
GO:1901615 | organic hydroxy compound metabolic process | 50.0% (36/72) | 4.07 | 0.0 | 0.0 |
GO:0016125 | sterol metabolic process | 30.56% (22/72) | 6.13 | 0.0 | 0.0 |
GO:0008610 | lipid biosynthetic process | 48.61% (35/72) | 3.38 | 0.0 | 0.0 |
GO:1902652 | secondary alcohol metabolic process | 22.22% (16/72) | 6.51 | 0.0 | 0.0 |
GO:0006629 | lipid metabolic process | 56.94% (41/72) | 2.92 | 0.0 | 0.0 |
GO:1901576 | organic substance biosynthetic process | 70.83% (51/72) | 2.25 | 0.0 | 0.0 |
GO:1901362 | organic cyclic compound biosynthetic process | 54.17% (39/72) | 2.93 | 0.0 | 0.0 |
GO:1902653 | secondary alcohol biosynthetic process | 19.44% (14/72) | 6.87 | 0.0 | 0.0 |
GO:0009058 | biosynthetic process | 70.83% (51/72) | 2.18 | 0.0 | 0.0 |
GO:0008152 | metabolic process | 95.83% (69/72) | 1.27 | 0.0 | 0.0 |
GO:0046165 | alcohol biosynthetic process | 23.61% (17/72) | 5.51 | 0.0 | 0.0 |
GO:0006695 | cholesterol biosynthetic process | 13.89% (10/72) | 7.95 | 0.0 | 0.0 |
GO:0006066 | alcohol metabolic process | 27.78% (20/72) | 4.61 | 0.0 | 0.0 |
GO:0008203 | cholesterol metabolic process | 15.28% (11/72) | 7.37 | 0.0 | 0.0 |
GO:1901360 | organic cyclic compound metabolic process | 66.67% (48/72) | 2.01 | 0.0 | 0.0 |
GO:1901135 | carbohydrate derivative metabolic process | 40.28% (29/72) | 3.14 | 0.0 | 0.0 |
GO:1901137 | carbohydrate derivative biosynthetic process | 30.56% (22/72) | 3.77 | 0.0 | 0.0 |
GO:0044255 | cellular lipid metabolic process | 43.06% (31/72) | 2.81 | 0.0 | 0.0 |
GO:0044281 | small molecule metabolic process | 51.39% (37/72) | 2.39 | 0.0 | 0.0 |
GO:0003824 | catalytic activity | 83.33% (60/72) | 1.34 | 0.0 | 0.0 |
GO:0016128 | phytosteroid metabolic process | 18.06% (13/72) | 5.52 | 0.0 | 0.0 |
GO:0016129 | phytosteroid biosynthetic process | 12.5% (9/72) | 6.73 | 0.0 | 0.0 |
GO:0044283 | small molecule biosynthetic process | 33.33% (24/72) | 3.02 | 0.0 | 0.0 |
GO:0006720 | isoprenoid metabolic process | 29.17% (21/72) | 3.36 | 0.0 | 0.0 |
GO:0016138 | glycoside biosynthetic process | 18.06% (13/72) | 4.87 | 0.0 | 0.0 |
GO:0071704 | organic substance metabolic process | 83.33% (60/72) | 1.17 | 0.0 | 0.0 |
GO:0090408 | phloem nitrate loading | 11.11% (8/72) | 6.96 | 0.0 | 0.0 |
GO:0090448 | glucosinolate:proton symporter activity | 11.11% (8/72) | 6.96 | 0.0 | 0.0 |
GO:0090449 | phloem glucosinolate loading | 11.11% (8/72) | 6.96 | 0.0 | 0.0 |
GO:0016104 | triterpenoid biosynthetic process | 12.5% (9/72) | 6.32 | 0.0 | 0.0 |
GO:0003674 | molecular_function | 98.61% (71/72) | 0.72 | 0.0 | 0.0 |
GO:0016137 | glycoside metabolic process | 19.44% (14/72) | 4.42 | 0.0 | 0.0 |
GO:0008299 | isoprenoid biosynthetic process | 26.39% (19/72) | 3.45 | 0.0 | 0.0 |
GO:0016134 | saponin metabolic process | 16.67% (12/72) | 4.93 | 0.0 | 0.0 |
GO:0044249 | cellular biosynthetic process | 52.78% (38/72) | 1.91 | 0.0 | 0.0 |
GO:1901349 | glucosinolate transport | 11.11% (8/72) | 6.63 | 0.0 | 0.0 |
GO:0016135 | saponin biosynthetic process | 15.28% (11/72) | 5.08 | 0.0 | 0.0 |
GO:0008150 | biological_process | 98.61% (71/72) | 0.68 | 0.0 | 0.0 |
GO:0006721 | terpenoid metabolic process | 23.61% (17/72) | 3.54 | 0.0 | 0.0 |
GO:0080054 | low-affinity nitrate transmembrane transporter activity | 11.11% (8/72) | 6.28 | 0.0 | 0.0 |
GO:0006084 | acetyl-CoA metabolic process | 12.5% (9/72) | 5.72 | 0.0 | 0.0 |
GO:1901659 | glycosyl compound biosynthetic process | 19.44% (14/72) | 4.03 | 0.0 | 0.0 |
GO:0010098 | suspensor development | 11.11% (8/72) | 6.23 | 0.0 | 0.0 |
GO:0006722 | triterpenoid metabolic process | 12.5% (9/72) | 5.65 | 0.0 | 0.0 |
GO:0016114 | terpenoid biosynthetic process | 20.83% (15/72) | 3.78 | 0.0 | 0.0 |
GO:0044238 | primary metabolic process | 73.61% (53/72) | 1.21 | 0.0 | 0.0 |
GO:0110126 | phloem loading | 11.11% (8/72) | 6.02 | 0.0 | 0.0 |
GO:0016491 | oxidoreductase activity | 34.72% (25/72) | 2.38 | 0.0 | 0.0 |
GO:0033865 | nucleoside bisphosphate metabolic process | 13.89% (10/72) | 4.76 | 0.0 | 0.0 |
GO:0033875 | ribonucleoside bisphosphate metabolic process | 13.89% (10/72) | 4.76 | 0.0 | 0.0 |
GO:0034032 | purine nucleoside bisphosphate metabolic process | 13.89% (10/72) | 4.76 | 0.0 | 0.0 |
GO:0042938 | dipeptide transport | 11.11% (8/72) | 5.63 | 0.0 | 0.0 |
GO:0015936 | coenzyme A metabolic process | 8.33% (6/72) | 7.03 | 0.0 | 0.0 |
GO:1901657 | glycosyl compound metabolic process | 22.22% (16/72) | 3.28 | 0.0 | 0.0 |
GO:0035251 | UDP-glucosyltransferase activity | 16.67% (12/72) | 4.07 | 0.0 | 0.0 |
GO:0015112 | nitrate transmembrane transporter activity | 11.11% (8/72) | 5.46 | 0.0 | 0.0 |
GO:0015706 | nitrate transmembrane transport | 11.11% (8/72) | 5.44 | 0.0 | 0.0 |
GO:0015295 | solute:proton symporter activity | 11.11% (8/72) | 5.36 | 0.0 | 0.0 |
GO:0046527 | glucosyltransferase activity | 16.67% (12/72) | 3.86 | 0.0 | 0.0 |
GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors | 13.89% (10/72) | 4.41 | 0.0 | 0.0 |
GO:0016758 | hexosyltransferase activity | 19.44% (14/72) | 3.4 | 0.0 | 0.0 |
GO:0035673 | oligopeptide transmembrane transporter activity | 11.11% (8/72) | 5.19 | 0.0 | 0.0 |
GO:1902025 | nitrate import | 11.11% (8/72) | 5.19 | 0.0 | 0.0 |
GO:0090407 | organophosphate biosynthetic process | 18.06% (13/72) | 3.59 | 0.0 | 0.0 |
GO:0006637 | acyl-CoA metabolic process | 12.5% (9/72) | 4.74 | 0.0 | 0.0 |
GO:0035383 | thioester metabolic process | 12.5% (9/72) | 4.74 | 0.0 | 0.0 |
GO:0006696 | ergosterol biosynthetic process | 6.94% (5/72) | 7.41 | 0.0 | 0.0 |
GO:0044108 | cellular alcohol biosynthetic process | 6.94% (5/72) | 7.41 | 0.0 | 0.0 |
GO:0006857 | oligopeptide transport | 11.11% (8/72) | 5.12 | 0.0 | 0.0 |
GO:1901682 | sulfur compound transmembrane transporter activity | 11.11% (8/72) | 5.11 | 0.0 | 0.0 |
GO:1904680 | peptide transmembrane transporter activity | 11.11% (8/72) | 5.05 | 0.0 | 0.0 |
GO:0008194 | UDP-glycosyltransferase activity | 18.06% (13/72) | 3.47 | 0.0 | 0.0 |
GO:0016131 | brassinosteroid metabolic process | 11.11% (8/72) | 5.01 | 0.0 | 0.0 |
GO:0008204 | ergosterol metabolic process | 6.94% (5/72) | 7.16 | 0.0 | 0.0 |
GO:0044107 | cellular alcohol metabolic process | 6.94% (5/72) | 7.16 | 0.0 | 0.0 |
GO:0010233 | phloem transport | 11.11% (8/72) | 4.97 | 0.0 | 0.0 |
GO:0015294 | solute:cation symporter activity | 11.11% (8/72) | 4.93 | 0.0 | 0.0 |
GO:0043562 | cellular response to nitrogen levels | 11.11% (8/72) | 4.88 | 0.0 | 0.0 |
GO:0009240 | isopentenyl diphosphate biosynthetic process | 8.33% (6/72) | 6.11 | 0.0 | 0.0 |
GO:0046490 | isopentenyl diphosphate metabolic process | 8.33% (6/72) | 6.11 | 0.0 | 0.0 |
GO:0102202 | soladodine glucosyltransferase activity | 5.56% (4/72) | 8.28 | 0.0 | 0.0 |
GO:0097384 | cellular lipid biosynthetic process | 6.94% (5/72) | 7.01 | 0.0 | 0.0 |
GO:0072348 | sulfur compound transport | 11.11% (8/72) | 4.85 | 0.0 | 0.0 |
GO:0050275 | scopoletin glucosyltransferase activity | 8.33% (6/72) | 6.03 | 0.0 | 0.0 |
GO:0015833 | peptide transport | 11.11% (8/72) | 4.78 | 0.0 | 0.0 |
GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors | 15.28% (11/72) | 3.69 | 0.0 | 0.0 |
GO:0016757 | glycosyltransferase activity | 19.44% (14/72) | 3.08 | 0.0 | 0.0 |
GO:0008654 | phospholipid biosynthetic process | 12.5% (9/72) | 4.24 | 0.0 | 0.0 |
GO:0010336 | gibberellic acid homeostasis | 9.72% (7/72) | 5.12 | 0.0 | 0.0 |
GO:0050403 | trans-zeatin O-beta-D-glucosyltransferase activity | 9.72% (7/72) | 5.12 | 0.0 | 0.0 |
GO:0098661 | inorganic anion transmembrane transport | 11.11% (8/72) | 4.56 | 0.0 | 0.0 |
GO:1901505 | carbohydrate derivative transmembrane transporter activity | 11.11% (8/72) | 4.51 | 0.0 | 0.0 |
GO:0010232 | vascular transport | 11.11% (8/72) | 4.5 | 0.0 | 0.0 |
GO:0042887 | amide transmembrane transporter activity | 11.11% (8/72) | 4.44 | 0.0 | 0.0 |
GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway | 6.94% (5/72) | 6.36 | 0.0 | 0.0 |
GO:0005886 | plasma membrane | 41.67% (30/72) | 1.61 | 0.0 | 0.0 |
GO:0080044 | quercetin 7-O-glucosyltransferase activity | 9.72% (7/72) | 4.86 | 0.0 | 0.0 |
GO:0003018 | vascular process in circulatory system | 11.11% (8/72) | 4.38 | 0.0 | 0.0 |
GO:0009150 | purine ribonucleotide metabolic process | 13.89% (10/72) | 3.69 | 0.0 | 0.0 |
GO:0016020 | membrane | 61.11% (44/72) | 1.12 | 0.0 | 0.0 |
GO:1901264 | carbohydrate derivative transport | 11.11% (8/72) | 4.36 | 0.0 | 0.0 |
GO:0055088 | lipid homeostasis | 12.5% (9/72) | 3.98 | 0.0 | 0.0 |
GO:0009987 | cellular process | 84.72% (61/72) | 0.7 | 0.0 | 0.0 |
GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 13.89% (10/72) | 3.66 | 0.0 | 0.0 |
GO:0019637 | organophosphate metabolic process | 20.83% (15/72) | 2.71 | 0.0 | 0.0 |
GO:0045540 | regulation of cholesterol biosynthetic process | 5.56% (4/72) | 7.38 | 0.0 | 0.0 |
GO:0006163 | purine nucleotide metabolic process | 13.89% (10/72) | 3.63 | 0.0 | 0.0 |
GO:0045337 | farnesyl diphosphate biosynthetic process | 5.56% (4/72) | 7.28 | 0.0 | 0.0 |
GO:0009259 | ribonucleotide metabolic process | 13.89% (10/72) | 3.57 | 0.0 | 0.0 |
GO:0015103 | inorganic anion transmembrane transporter activity | 11.11% (8/72) | 4.22 | 0.0 | 0.0 |
GO:0110165 | cellular anatomical entity | 90.28% (65/72) | 0.59 | 0.0 | 0.0 |
GO:0003013 | circulatory system process | 11.11% (8/72) | 4.21 | 0.0 | 0.0 |
GO:0015293 | symporter activity | 11.11% (8/72) | 4.2 | 0.0 | 0.0 |
GO:0044237 | cellular metabolic process | 66.67% (48/72) | 0.98 | 0.0 | 0.0 |
GO:0019693 | ribose phosphate metabolic process | 13.89% (10/72) | 3.54 | 0.0 | 0.0 |
GO:0042886 | amide transport | 11.11% (8/72) | 4.18 | 0.0 | 0.0 |
GO:0006807 | nitrogen compound metabolic process | 59.72% (43/72) | 1.1 | 0.0 | 0.0 |
GO:0006790 | sulfur compound metabolic process | 19.44% (14/72) | 2.74 | 0.0 | 0.0 |
GO:0106118 | regulation of sterol biosynthetic process | 5.56% (4/72) | 7.08 | 0.0 | 0.0 |
GO:0006644 | phospholipid metabolic process | 13.89% (10/72) | 3.48 | 0.0 | 0.0 |
GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor | 9.72% (7/72) | 4.54 | 0.0 | 0.0 |
GO:0010083 | regulation of vegetative meristem growth | 6.94% (5/72) | 5.88 | 0.0 | 0.0 |
GO:0080043 | quercetin 3-O-glucosyltransferase activity | 9.72% (7/72) | 4.52 | 0.0 | 0.0 |
GO:0005575 | cellular_component | 90.28% (65/72) | 0.56 | 0.0 | 0.0 |
GO:0042445 | hormone metabolic process | 15.28% (11/72) | 3.21 | 0.0 | 0.0 |
GO:0050404 | zeatin O-beta-D-xylosyltransferase activity | 6.94% (5/72) | 5.82 | 0.0 | 0.0 |
GO:0010817 | regulation of hormone levels | 20.83% (15/72) | 2.48 | 0.0 | 1e-06 |
GO:0001878 | response to yeast | 4.17% (3/72) | 8.35 | 0.0 | 1e-06 |
GO:0072521 | purine-containing compound metabolic process | 13.89% (10/72) | 3.31 | 0.0 | 1e-06 |
GO:0015698 | inorganic anion transport | 11.11% (8/72) | 3.89 | 0.0 | 1e-06 |
GO:0048439 | flower morphogenesis | 6.94% (5/72) | 5.57 | 0.0 | 1e-06 |
GO:0032502 | developmental process | 56.94% (41/72) | 1.08 | 0.0 | 1e-06 |
GO:0046912 | acyltransferase activity, acyl groups converted into alkyl on transfer | 5.56% (4/72) | 6.56 | 0.0 | 1e-06 |
GO:0070402 | NADPH binding | 6.94% (5/72) | 5.5 | 0.0 | 1e-06 |
GO:0015078 | proton transmembrane transporter activity | 11.11% (8/72) | 3.82 | 0.0 | 1e-06 |
GO:0004420 | hydroxymethylglutaryl-CoA reductase (NADPH) activity | 4.17% (3/72) | 8.08 | 0.0 | 1e-06 |
GO:0003878 | ATP citrate synthase activity | 4.17% (3/72) | 8.08 | 0.0 | 1e-06 |
GO:0065008 | regulation of biological quality | 34.72% (25/72) | 1.59 | 0.0 | 2e-06 |
GO:0090181 | regulation of cholesterol metabolic process | 5.56% (4/72) | 6.23 | 0.0 | 2e-06 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 15.28% (11/72) | 2.88 | 0.0 | 3e-06 |
GO:0016132 | brassinosteroid biosynthetic process | 5.56% (4/72) | 6.18 | 0.0 | 3e-06 |
GO:0070085 | glycosylation | 9.72% (7/72) | 4.01 | 0.0 | 3e-06 |
GO:0031669 | cellular response to nutrient levels | 15.28% (11/72) | 2.86 | 0.0 | 3e-06 |
GO:0035252 | UDP-xylosyltransferase activity | 6.94% (5/72) | 5.1 | 0.0 | 4e-06 |
GO:0016853 | isomerase activity | 11.11% (8/72) | 3.57 | 0.0 | 4e-06 |
GO:0009991 | response to extracellular stimulus | 19.44% (14/72) | 2.36 | 0.0 | 4e-06 |
GO:0031667 | response to nutrient levels | 18.06% (13/72) | 2.49 | 0.0 | 4e-06 |
GO:0031668 | cellular response to extracellular stimulus | 16.67% (12/72) | 2.64 | 0.0 | 4e-06 |
GO:0042285 | xylosyltransferase activity | 6.94% (5/72) | 4.98 | 1e-06 | 5e-06 |
GO:0009117 | nucleotide metabolic process | 13.89% (10/72) | 2.97 | 1e-06 | 5e-06 |
GO:0120178 | steroid hormone biosynthetic process | 5.56% (4/72) | 5.91 | 1e-06 | 5e-06 |
GO:0045338 | farnesyl diphosphate metabolic process | 6.94% (5/72) | 4.96 | 1e-06 | 5e-06 |
GO:0048856 | anatomical structure development | 45.83% (33/72) | 1.2 | 1e-06 | 6e-06 |
GO:0018130 | heterocycle biosynthetic process | 20.83% (15/72) | 2.2 | 1e-06 | 6e-06 |
GO:0006753 | nucleoside phosphate metabolic process | 13.89% (10/72) | 2.94 | 1e-06 | 6e-06 |
GO:1902123 | (-)-pinoresinol catabolic process | 4.17% (3/72) | 7.35 | 1e-06 | 6e-06 |
GO:0071496 | cellular response to external stimulus | 16.67% (12/72) | 2.57 | 1e-06 | 6e-06 |
GO:0016740 | transferase activity | 38.89% (28/72) | 1.37 | 1e-06 | 6e-06 |
GO:0006085 | acetyl-CoA biosynthetic process | 5.56% (4/72) | 5.84 | 1e-06 | 6e-06 |
GO:1905613 | regulation of developmental vegetative growth | 6.94% (5/72) | 4.85 | 1e-06 | 8e-06 |
GO:1902127 | (-)-lariciresinol metabolic process | 4.17% (3/72) | 7.21 | 1e-06 | 8e-06 |
GO:1902129 | (-)-lariciresinol biosynthetic process | 4.17% (3/72) | 7.21 | 1e-06 | 8e-06 |
GO:0050661 | NADP binding | 8.33% (6/72) | 4.17 | 1e-06 | 9e-06 |
GO:0006101 | citrate metabolic process | 4.17% (3/72) | 7.08 | 1e-06 | 1e-05 |
GO:0010284 | lariciresinol reductase activity | 4.17% (3/72) | 7.08 | 1e-06 | 1e-05 |
GO:0032442 | phenylcoumaran benzylic ether reductase activity | 4.17% (3/72) | 7.08 | 1e-06 | 1e-05 |
GO:0046273 | lignan catabolic process | 4.17% (3/72) | 7.08 | 1e-06 | 1e-05 |
GO:1901502 | ether catabolic process | 4.17% (3/72) | 7.08 | 1e-06 | 1e-05 |
GO:1902124 | (+)-pinoresinol metabolic process | 4.17% (3/72) | 7.08 | 1e-06 | 1e-05 |
GO:1902125 | (+)-pinoresinol catabolic process | 4.17% (3/72) | 7.08 | 1e-06 | 1e-05 |
GO:1902130 | (+)-lariciresinol metabolic process | 4.17% (3/72) | 7.08 | 1e-06 | 1e-05 |
GO:1902132 | (+)-lariciresinol biosynthetic process | 4.17% (3/72) | 7.08 | 1e-06 | 1e-05 |
GO:1901564 | organonitrogen compound metabolic process | 47.22% (34/72) | 1.12 | 2e-06 | 1.2e-05 |
GO:0031090 | organelle membrane | 34.72% (25/72) | 1.44 | 2e-06 | 1.3e-05 |
GO:0010283 | pinoresinol reductase activity | 4.17% (3/72) | 6.97 | 2e-06 | 1.3e-05 |
GO:1901598 | (-)-pinoresinol metabolic process | 4.17% (3/72) | 6.97 | 2e-06 | 1.3e-05 |
GO:0098656 | anion transmembrane transport | 11.11% (8/72) | 3.27 | 2e-06 | 1.4e-05 |
GO:0046483 | heterocycle metabolic process | 34.72% (25/72) | 1.4 | 3e-06 | 2e-05 |
GO:0022853 | active ion transmembrane transporter activity | 11.11% (8/72) | 3.2 | 3e-06 | 2.1e-05 |
GO:0003006 | developmental process involved in reproduction | 36.11% (26/72) | 1.35 | 3e-06 | 2.3e-05 |
GO:0009653 | anatomical structure morphogenesis | 27.78% (20/72) | 1.64 | 3e-06 | 2.3e-05 |
GO:0042579 | microbody | 12.5% (9/72) | 2.9 | 3e-06 | 2.5e-05 |
GO:0047918 | GDP-mannose 3,5-epimerase activity | 2.78% (2/72) | 9.08 | 3e-06 | 2.5e-05 |
GO:0043603 | cellular amide metabolic process | 15.28% (11/72) | 2.51 | 3e-06 | 2.6e-05 |
GO:0035384 | thioester biosynthetic process | 5.56% (4/72) | 5.23 | 4e-06 | 3.1e-05 |
GO:0071616 | acyl-CoA biosynthetic process | 5.56% (4/72) | 5.23 | 4e-06 | 3.1e-05 |
GO:0019336 | phenol-containing compound catabolic process | 5.56% (4/72) | 5.2 | 4e-06 | 3.3e-05 |
GO:0010380 | regulation of chlorophyll biosynthetic process | 6.94% (5/72) | 4.37 | 5e-06 | 3.4e-05 |
GO:0050896 | response to stimulus | 65.28% (47/72) | 0.75 | 5e-06 | 3.4e-05 |
GO:0015291 | secondary active transmembrane transporter activity | 11.11% (8/72) | 3.09 | 5e-06 | 3.4e-05 |
GO:0043231 | intracellular membrane-bounded organelle | 61.11% (44/72) | 0.81 | 5e-06 | 3.7e-05 |
GO:1901463 | regulation of tetrapyrrole biosynthetic process | 6.94% (5/72) | 4.34 | 5e-06 | 3.7e-05 |
GO:0007154 | cell communication | 16.67% (12/72) | 2.28 | 6e-06 | 4.3e-05 |
GO:0009605 | response to external stimulus | 43.06% (31/72) | 1.11 | 7e-06 | 4.7e-05 |
GO:0006107 | oxaloacetate metabolic process | 4.17% (3/72) | 6.35 | 7e-06 | 4.7e-05 |
GO:1901503 | ether biosynthetic process | 4.17% (3/72) | 6.35 | 7e-06 | 4.7e-05 |
GO:0043227 | membrane-bounded organelle | 61.11% (44/72) | 0.79 | 7e-06 | 5e-05 |
GO:0070723 | response to cholesterol | 4.17% (3/72) | 6.28 | 8e-06 | 5.4e-05 |
GO:0050810 | regulation of steroid biosynthetic process | 5.56% (4/72) | 5.0 | 8e-06 | 5.5e-05 |
GO:0090056 | regulation of chlorophyll metabolic process | 6.94% (5/72) | 4.16 | 9e-06 | 6.5e-05 |
GO:0000248 | C-5 sterol desaturase activity | 2.78% (2/72) | 8.5 | 1e-05 | 6.6e-05 |
GO:0050046 | delta7-sterol 5(6)-desaturase activity | 2.78% (2/72) | 8.5 | 1e-05 | 6.6e-05 |
GO:0140615 | ATP-dependent citrate lyase complex | 2.78% (2/72) | 8.5 | 1e-05 | 6.6e-05 |
GO:0047598 | 7-dehydrocholesterol reductase activity | 2.78% (2/72) | 8.5 | 1e-05 | 6.6e-05 |
GO:0047248 | nuatigenin 3-beta-glucosyltransferase activity | 2.78% (2/72) | 8.5 | 1e-05 | 6.6e-05 |
GO:0033849 | chrysanthemyl diphosphate synthase activity | 2.78% (2/72) | 8.5 | 1e-05 | 6.6e-05 |
GO:0033851 | lavandulyl diphosphate synthase activity | 2.78% (2/72) | 8.5 | 1e-05 | 6.6e-05 |
GO:0045542 | positive regulation of cholesterol biosynthetic process | 2.78% (2/72) | 8.5 | 1e-05 | 6.6e-05 |
GO:0090205 | positive regulation of cholesterol metabolic process | 2.78% (2/72) | 8.5 | 1e-05 | 6.6e-05 |
GO:0106120 | positive regulation of sterol biosynthetic process | 2.78% (2/72) | 8.5 | 1e-05 | 6.6e-05 |
GO:0033866 | nucleoside bisphosphate biosynthetic process | 5.56% (4/72) | 4.89 | 1e-05 | 6.7e-05 |
GO:0034030 | ribonucleoside bisphosphate biosynthetic process | 5.56% (4/72) | 4.89 | 1e-05 | 6.7e-05 |
GO:0034033 | purine nucleoside bisphosphate biosynthetic process | 5.56% (4/72) | 4.89 | 1e-05 | 6.7e-05 |
GO:0008509 | anion transmembrane transporter activity | 11.11% (8/72) | 2.93 | 1e-05 | 6.7e-05 |
GO:0010584 | pollen exine formation | 6.94% (5/72) | 4.13 | 1e-05 | 6.7e-05 |
GO:0016763 | pentosyltransferase activity | 6.94% (5/72) | 4.13 | 1e-05 | 6.7e-05 |
GO:0072350 | tricarboxylic acid metabolic process | 4.17% (3/72) | 6.15 | 1e-05 | 6.8e-05 |
GO:1901401 | regulation of tetrapyrrole metabolic process | 6.94% (5/72) | 4.12 | 1.1e-05 | 6.8e-05 |
GO:0034312 | diol biosynthetic process | 4.17% (3/72) | 6.08 | 1.2e-05 | 7.5e-05 |
GO:0005794 | Golgi apparatus | 16.67% (12/72) | 2.16 | 1.3e-05 | 8.2e-05 |
GO:0048608 | reproductive structure development | 15.28% (11/72) | 2.3 | 1.3e-05 | 8.3e-05 |
GO:0034311 | diol metabolic process | 4.17% (3/72) | 5.97 | 1.5e-05 | 9.4e-05 |
GO:0005783 | endoplasmic reticulum | 18.06% (13/72) | 2.02 | 1.6e-05 | 9.9e-05 |
GO:0022414 | reproductive process | 38.89% (28/72) | 1.14 | 1.6e-05 | 0.0001 |
GO:0070704 | sterol desaturase activity | 2.78% (2/72) | 8.08 | 2e-05 | 0.000122 |
GO:0102203 | brassicasterol glucosyltransferase activity | 2.78% (2/72) | 8.08 | 2e-05 | 0.000122 |
GO:0102205 | cholesterol alpha-glucosyltransferase activity | 2.78% (2/72) | 8.08 | 2e-05 | 0.000122 |
GO:0043436 | oxoacid metabolic process | 22.22% (16/72) | 1.71 | 2.1e-05 | 0.000128 |
GO:0036314 | response to sterol | 4.17% (3/72) | 5.81 | 2.1e-05 | 0.000128 |
GO:0070542 | response to fatty acid | 12.5% (9/72) | 2.56 | 2.2e-05 | 0.000132 |
GO:0098660 | inorganic ion transmembrane transport | 11.11% (8/72) | 2.77 | 2.3e-05 | 0.000137 |
GO:0010016 | shoot system morphogenesis | 6.94% (5/72) | 3.88 | 2.4e-05 | 0.000146 |
GO:0019218 | regulation of steroid metabolic process | 5.56% (4/72) | 4.58 | 2.5e-05 | 0.000149 |
GO:0030166 | proteoglycan biosynthetic process | 4.17% (3/72) | 5.72 | 2.6e-05 | 0.000154 |
GO:0006725 | cellular aromatic compound metabolic process | 34.72% (25/72) | 1.2 | 2.9e-05 | 0.000172 |
GO:0009705 | plant-type vacuole membrane | 9.72% (7/72) | 2.98 | 3e-05 | 0.000178 |
GO:0034309 | primary alcohol biosynthetic process | 4.17% (3/72) | 5.63 | 3.1e-05 | 0.000183 |
GO:0008584 | male gonad development | 4.17% (3/72) | 5.63 | 3.1e-05 | 0.000183 |
GO:0080167 | response to karrikin | 11.11% (8/72) | 2.7 | 3.2e-05 | 0.000187 |
GO:0051507 | beta-sitosterol UDP-glucosyltransferase activity | 2.78% (2/72) | 7.76 | 3.3e-05 | 0.000192 |
GO:0033384 | geranyl diphosphate biosynthetic process | 2.78% (2/72) | 7.76 | 3.3e-05 | 0.000192 |
GO:0050502 | cis-zeatin O-beta-D-glucosyltransferase activity | 5.56% (4/72) | 4.47 | 3.4e-05 | 0.000192 |
GO:0022890 | inorganic cation transmembrane transporter activity | 11.11% (8/72) | 2.66 | 3.8e-05 | 0.000218 |
GO:0009826 | unidimensional cell growth | 13.89% (10/72) | 2.27 | 4e-05 | 0.000227 |
GO:0048316 | seed development | 8.33% (6/72) | 3.25 | 4.1e-05 | 0.000234 |
GO:0006082 | organic acid metabolic process | 22.22% (16/72) | 1.63 | 4.2e-05 | 0.000234 |
GO:0006486 | protein glycosylation | 6.94% (5/72) | 3.7 | 4.4e-05 | 0.000244 |
GO:0043413 | macromolecule glycosylation | 6.94% (5/72) | 3.7 | 4.4e-05 | 0.000244 |
GO:0044272 | sulfur compound biosynthetic process | 9.72% (7/72) | 2.9 | 4.4e-05 | 0.000244 |
GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor | 4.17% (3/72) | 5.46 | 4.5e-05 | 0.000247 |
GO:0046148 | pigment biosynthetic process | 8.33% (6/72) | 3.22 | 4.6e-05 | 0.000256 |
GO:0003008 | system process | 11.11% (8/72) | 2.62 | 4.7e-05 | 0.000257 |
GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives | 4.17% (3/72) | 5.42 | 4.8e-05 | 0.000265 |
GO:0016906 | sterol 3-beta-glucosyltransferase activity | 2.78% (2/72) | 7.5 | 5e-05 | 0.000272 |
GO:0030259 | lipid glycosylation | 2.78% (2/72) | 7.5 | 5e-05 | 0.000272 |
GO:0046271 | phenylpropanoid catabolic process | 4.17% (3/72) | 5.38 | 5.2e-05 | 0.000283 |
GO:0010208 | pollen wall assembly | 6.94% (5/72) | 3.63 | 5.4e-05 | 0.000294 |
GO:0051555 | flavonol biosynthetic process | 4.17% (3/72) | 5.35 | 5.6e-05 | 0.000304 |
GO:0051554 | flavonol metabolic process | 4.17% (3/72) | 5.28 | 6.5e-05 | 0.000349 |
GO:0071398 | cellular response to fatty acid | 4.17% (3/72) | 5.28 | 6.5e-05 | 0.000349 |
GO:0019852 | L-ascorbic acid metabolic process | 4.17% (3/72) | 5.24 | 7e-05 | 0.000368 |
GO:0033574 | response to testosterone | 4.17% (3/72) | 5.24 | 7e-05 | 0.000368 |
GO:0010142 | farnesyl diphosphate biosynthetic process, mevalonate pathway | 2.78% (2/72) | 7.28 | 7e-05 | 0.000369 |
GO:1902767 | isoprenoid biosynthetic process via mevalonate | 2.78% (2/72) | 7.28 | 7e-05 | 0.000369 |
GO:0004161 | dimethylallyltranstransferase activity | 2.78% (2/72) | 7.28 | 7e-05 | 0.000369 |
GO:0009100 | glycoprotein metabolic process | 5.56% (4/72) | 4.19 | 7.2e-05 | 0.000374 |
GO:0009860 | pollen tube growth | 9.72% (7/72) | 2.76 | 7.9e-05 | 0.000409 |
GO:0010015 | root morphogenesis | 8.33% (6/72) | 3.08 | 7.9e-05 | 0.000412 |
GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 12.5% (9/72) | 2.31 | 8.2e-05 | 0.000421 |
GO:1901361 | organic cyclic compound catabolic process | 11.11% (8/72) | 2.51 | 8.2e-05 | 0.000422 |
GO:0009806 | lignan metabolic process | 4.17% (3/72) | 5.15 | 8.6e-05 | 0.000438 |
GO:0009807 | lignan biosynthetic process | 4.17% (3/72) | 5.15 | 8.6e-05 | 0.000438 |
GO:0006820 | anion transport | 11.11% (8/72) | 2.5 | 8.5e-05 | 0.000438 |
GO:0009753 | response to jasmonic acid | 11.11% (8/72) | 2.49 | 8.9e-05 | 0.000453 |
GO:0019745 | pentacyclic triterpenoid biosynthetic process | 4.17% (3/72) | 5.11 | 9.2e-05 | 0.000464 |
GO:1902930 | regulation of alcohol biosynthetic process | 5.56% (4/72) | 4.1 | 9.2e-05 | 0.000464 |
GO:0009101 | glycoprotein biosynthetic process | 4.17% (3/72) | 5.08 | 9.8e-05 | 0.00049 |
GO:0004659 | prenyltransferase activity | 4.17% (3/72) | 5.05 | 0.000104 | 0.00052 |
GO:0051553 | flavone biosynthetic process | 4.17% (3/72) | 5.03 | 0.00011 | 0.00055 |
GO:0098588 | bounding membrane of organelle | 22.22% (16/72) | 1.51 | 0.000115 | 0.000572 |
GO:0009813 | flavonoid biosynthetic process | 8.33% (6/72) | 2.98 | 0.000116 | 0.000576 |
GO:0046950 | cellular ketone body metabolic process | 2.78% (2/72) | 6.91 | 0.000119 | 0.000587 |
GO:0050139 | nicotinate-N-glucosyltransferase activity | 2.78% (2/72) | 6.91 | 0.000119 | 0.000587 |
GO:0006029 | proteoglycan metabolic process | 4.17% (3/72) | 4.97 | 0.000124 | 0.000608 |
GO:0008324 | cation transmembrane transporter activity | 11.11% (8/72) | 2.41 | 0.000127 | 0.00062 |
GO:0006767 | water-soluble vitamin metabolic process | 5.56% (4/72) | 3.98 | 0.000127 | 0.00062 |
GO:1901616 | organic hydroxy compound catabolic process | 5.56% (4/72) | 3.93 | 0.000142 | 0.000687 |
GO:1902128 | (-)-lariciresinol catabolic process | 2.78% (2/72) | 6.76 | 0.000149 | 0.000704 |
GO:1902133 | (+)-secoisolariciresinol metabolic process | 2.78% (2/72) | 6.76 | 0.000149 | 0.000704 |
GO:1902135 | (+)-secoisolariciresinol biosynthetic process | 2.78% (2/72) | 6.76 | 0.000149 | 0.000704 |
GO:0047807 | cytokinin 7-beta-glucosyltransferase activity | 2.78% (2/72) | 6.76 | 0.000149 | 0.000704 |
GO:0080062 | cytokinin 9-beta-glucosyltransferase activity | 2.78% (2/72) | 6.76 | 0.000149 | 0.000704 |
GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development | 2.78% (2/72) | 6.76 | 0.000149 | 0.000704 |
GO:1901334 | lactone metabolic process | 4.17% (3/72) | 4.89 | 0.000147 | 0.000709 |
GO:0005789 | endoplasmic reticulum membrane | 12.5% (9/72) | 2.2 | 0.000147 | 0.000709 |
GO:0008406 | gonad development | 4.17% (3/72) | 4.86 | 0.000155 | 0.000728 |
GO:0051552 | flavone metabolic process | 4.17% (3/72) | 4.84 | 0.000163 | 0.000765 |
GO:0010438 | cellular response to sulfur starvation | 4.17% (3/72) | 4.81 | 0.000172 | 0.000803 |
GO:0042440 | pigment metabolic process | 8.33% (6/72) | 2.87 | 0.000179 | 0.000832 |
GO:1902224 | ketone body metabolic process | 2.78% (2/72) | 6.63 | 0.000182 | 0.000834 |
GO:0055023 | positive regulation of cardiac muscle tissue growth | 2.78% (2/72) | 6.63 | 0.000182 | 0.000834 |
GO:0060421 | positive regulation of heart growth | 2.78% (2/72) | 6.63 | 0.000182 | 0.000834 |
GO:0046173 | polyol biosynthetic process | 4.17% (3/72) | 4.79 | 0.000181 | 0.000837 |
GO:0009965 | leaf morphogenesis | 6.94% (5/72) | 3.26 | 0.000181 | 0.000839 |
GO:0005774 | vacuolar membrane | 16.67% (12/72) | 1.75 | 0.0002 | 0.000914 |
GO:0009152 | purine ribonucleotide biosynthetic process | 5.56% (4/72) | 3.78 | 0.000213 | 0.000972 |
GO:0022804 | active transmembrane transporter activity | 11.11% (8/72) | 2.3 | 0.00022 | 0.000996 |
GO:1901566 | organonitrogen compound biosynthetic process | 18.06% (13/72) | 1.64 | 0.000224 | 0.001013 |
GO:0043229 | intracellular organelle | 61.11% (44/72) | 0.61 | 0.000227 | 0.001025 |
GO:0019752 | carboxylic acid metabolic process | 18.06% (13/72) | 1.64 | 0.000231 | 0.001034 |
GO:0009932 | cell tip growth | 9.72% (7/72) | 2.51 | 0.00023 | 0.001035 |
GO:0010927 | cellular component assembly involved in morphogenesis | 6.94% (5/72) | 3.17 | 0.00024 | 0.001073 |
GO:0019438 | aromatic compound biosynthetic process | 18.06% (13/72) | 1.63 | 0.000248 | 0.001105 |
GO:0015318 | inorganic molecular entity transmembrane transporter activity | 11.11% (8/72) | 2.26 | 0.000263 | 0.001167 |
GO:0043226 | organelle | 61.11% (44/72) | 0.61 | 0.000264 | 0.001169 |
GO:0006164 | purine nucleotide biosynthetic process | 5.56% (4/72) | 3.69 | 0.00027 | 0.001189 |
GO:0009725 | response to hormone | 26.39% (19/72) | 1.23 | 0.000281 | 0.001236 |
GO:0014070 | response to organic cyclic compound | 16.67% (12/72) | 1.7 | 0.000282 | 0.001237 |
GO:0006793 | phosphorus metabolic process | 22.22% (16/72) | 1.37 | 0.000329 | 0.001438 |
GO:0060560 | developmental growth involved in morphogenesis | 13.89% (10/72) | 1.89 | 0.000338 | 0.001472 |
GO:0047893 | flavonol 3-O-glucosyltransferase activity | 2.78% (2/72) | 6.18 | 0.000346 | 0.001497 |
GO:0004337 | geranyltranstransferase activity | 2.78% (2/72) | 6.18 | 0.000346 | 0.001497 |
GO:0019742 | pentacyclic triterpenoid metabolic process | 4.17% (3/72) | 4.46 | 0.000354 | 0.001526 |
GO:1901654 | response to ketone | 5.56% (4/72) | 3.58 | 0.000365 | 0.001572 |
GO:0006766 | vitamin metabolic process | 5.56% (4/72) | 3.57 | 0.000373 | 0.0016 |
GO:0010075 | regulation of meristem growth | 6.94% (5/72) | 3.02 | 0.000387 | 0.001655 |
GO:0042221 | response to chemical | 43.06% (31/72) | 0.82 | 0.00039 | 0.001663 |
GO:0034220 | ion transmembrane transport | 11.11% (8/72) | 2.17 | 0.000406 | 0.001724 |
GO:0009260 | ribonucleotide biosynthetic process | 5.56% (4/72) | 3.53 | 0.000413 | 0.001745 |
GO:0018904 | ether metabolic process | 4.17% (3/72) | 4.38 | 0.000413 | 0.001749 |
GO:0009812 | flavonoid metabolic process | 8.33% (6/72) | 2.64 | 0.000417 | 0.001756 |
GO:0048589 | developmental growth | 15.28% (11/72) | 1.73 | 0.000431 | 0.00181 |
GO:0061050 | regulation of cell growth involved in cardiac muscle cell development | 2.78% (2/72) | 6.0 | 0.000447 | 0.001871 |
GO:0016053 | organic acid biosynthetic process | 12.5% (9/72) | 1.97 | 0.000474 | 0.001979 |
GO:0046390 | ribose phosphate biosynthetic process | 5.56% (4/72) | 3.46 | 0.000493 | 0.00205 |
GO:0016021 | integral component of membrane | 20.83% (15/72) | 1.38 | 0.000508 | 0.002108 |
GO:0016854 | racemase and epimerase activity | 4.17% (3/72) | 4.28 | 0.000513 | 0.002123 |
GO:0005777 | peroxisome | 8.33% (6/72) | 2.57 | 0.000523 | 0.002156 |
GO:0032501 | multicellular organismal process | 34.72% (25/72) | 0.95 | 0.000525 | 0.002158 |
GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds | 2.78% (2/72) | 5.84 | 0.000561 | 0.0023 |
GO:0000902 | cell morphogenesis | 13.89% (10/72) | 1.78 | 0.000616 | 0.002521 |
GO:0009719 | response to endogenous stimulus | 26.39% (19/72) | 1.14 | 0.000656 | 0.002677 |
GO:0006805 | xenobiotic metabolic process | 4.17% (3/72) | 4.15 | 0.000669 | 0.002721 |
GO:0043648 | dicarboxylic acid metabolic process | 5.56% (4/72) | 3.34 | 0.000683 | 0.002763 |
GO:0019748 | secondary metabolic process | 15.28% (11/72) | 1.65 | 0.000683 | 0.002767 |
GO:0043434 | response to peptide hormone | 5.56% (4/72) | 3.33 | 0.000695 | 0.002795 |
GO:0031224 | intrinsic component of membrane | 22.22% (16/72) | 1.28 | 0.000694 | 0.002797 |
GO:0055085 | transmembrane transport | 13.89% (10/72) | 1.75 | 0.000716 | 0.00287 |
GO:0071705 | nitrogen compound transport | 15.28% (11/72) | 1.63 | 0.000796 | 0.003184 |
GO:0036094 | small molecule binding | 25.0% (18/72) | 1.16 | 0.0008 | 0.003189 |
GO:0044282 | small molecule catabolic process | 8.33% (6/72) | 2.46 | 0.000803 | 0.003191 |
GO:0005829 | cytosol | 29.17% (21/72) | 1.03 | 0.000819 | 0.003246 |
GO:0006796 | phosphate-containing compound metabolic process | 20.83% (15/72) | 1.3 | 0.000857 | 0.003388 |
GO:0035578 | azurophil granule lumen | 2.78% (2/72) | 5.5 | 0.0009 | 0.003536 |
GO:0046622 | positive regulation of organ growth | 2.78% (2/72) | 5.5 | 0.0009 | 0.003536 |
GO:0016049 | cell growth | 13.89% (10/72) | 1.7 | 0.000938 | 0.003676 |
GO:0034698 | response to gonadotropin | 2.78% (2/72) | 5.44 | 0.000977 | 0.003786 |
GO:0010613 | positive regulation of cardiac muscle hypertrophy | 2.78% (2/72) | 5.44 | 0.000977 | 0.003786 |
GO:0014742 | positive regulation of muscle hypertrophy | 2.78% (2/72) | 5.44 | 0.000977 | 0.003786 |
GO:0048513 | animal organ development | 11.11% (8/72) | 1.97 | 0.000973 | 0.003801 |
GO:0045926 | negative regulation of growth | 6.94% (5/72) | 2.72 | 0.000985 | 0.003807 |
GO:0090698 | post-embryonic plant morphogenesis | 8.33% (6/72) | 2.39 | 0.001001 | 0.003859 |
GO:0009793 | embryo development ending in seed dormancy | 11.11% (8/72) | 1.96 | 0.001013 | 0.003893 |
GO:0071702 | organic substance transport | 16.67% (12/72) | 1.48 | 0.001078 | 0.004135 |
GO:0005778 | peroxisomal membrane | 4.17% (3/72) | 3.89 | 0.001123 | 0.004271 |
GO:0031903 | microbody membrane | 4.17% (3/72) | 3.89 | 0.001123 | 0.004271 |
GO:0046394 | carboxylic acid biosynthetic process | 11.11% (8/72) | 1.94 | 0.001122 | 0.00429 |
GO:0072522 | purine-containing compound biosynthetic process | 5.56% (4/72) | 3.14 | 0.001143 | 0.004336 |
GO:0019751 | polyol metabolic process | 4.17% (3/72) | 3.88 | 0.001153 | 0.00436 |
GO:0044550 | secondary metabolite biosynthetic process | 12.5% (9/72) | 1.78 | 0.001175 | 0.004432 |
GO:0042364 | water-soluble vitamin biosynthetic process | 4.17% (3/72) | 3.84 | 0.001245 | 0.00467 |
GO:0034308 | primary alcohol metabolic process | 4.17% (3/72) | 3.84 | 0.001245 | 0.00467 |
GO:0031974 | membrane-enclosed lumen | 9.72% (7/72) | 2.08 | 0.001314 | 0.004891 |
GO:0043233 | organelle lumen | 9.72% (7/72) | 2.08 | 0.001314 | 0.004891 |
GO:0070013 | intracellular organelle lumen | 9.72% (7/72) | 2.08 | 0.001314 | 0.004891 |
GO:0048588 | developmental cell growth | 9.72% (7/72) | 2.07 | 0.001382 | 0.005133 |
GO:0047209 | coniferyl-alcohol glucosyltransferase activity | 2.78% (2/72) | 5.18 | 0.001408 | 0.0052 |
GO:0015075 | ion transmembrane transporter activity | 11.11% (8/72) | 1.89 | 0.001406 | 0.005206 |
GO:0043167 | ion binding | 33.33% (24/72) | 0.88 | 0.001454 | 0.005358 |
GO:0051155 | positive regulation of striated muscle cell differentiation | 2.78% (2/72) | 5.13 | 0.001503 | 0.005523 |
GO:0040007 | growth | 15.28% (11/72) | 1.5 | 0.001583 | 0.005802 |
GO:0009165 | nucleotide biosynthetic process | 5.56% (4/72) | 3.0 | 0.001606 | 0.005871 |
GO:0019853 | L-ascorbic acid biosynthetic process | 2.78% (2/72) | 5.04 | 0.001703 | 0.00616 |
GO:0016229 | steroid dehydrogenase activity | 2.78% (2/72) | 5.04 | 0.001703 | 0.00616 |
GO:0051149 | positive regulation of muscle cell differentiation | 2.78% (2/72) | 5.04 | 0.001703 | 0.00616 |
GO:0055021 | regulation of cardiac muscle tissue growth | 2.78% (2/72) | 5.04 | 0.001703 | 0.00616 |
GO:1901293 | nucleoside phosphate biosynthetic process | 5.56% (4/72) | 2.98 | 0.001717 | 0.006195 |
GO:0072330 | monocarboxylic acid biosynthetic process | 8.33% (6/72) | 2.23 | 0.001749 | 0.006297 |
GO:0008398 | sterol 14-demethylase activity | 1.39% (1/72) | 9.08 | 0.001842 | 0.006402 |
GO:0033488 | cholesterol biosynthetic process via 24,25-dihydrolanosterol | 1.39% (1/72) | 9.08 | 0.001842 | 0.006402 |
GO:1900222 | negative regulation of amyloid-beta clearance | 1.39% (1/72) | 9.08 | 0.001842 | 0.006402 |
GO:0033490 | cholesterol biosynthetic process via lathosterol | 1.39% (1/72) | 9.08 | 0.001842 | 0.006402 |
GO:0000247 | C-8 sterol isomerase activity | 1.39% (1/72) | 9.08 | 0.001842 | 0.006402 |
GO:0004769 | steroid delta-isomerase activity | 1.39% (1/72) | 9.08 | 0.001842 | 0.006402 |
GO:0050613 | delta14-sterol reductase activity | 1.39% (1/72) | 9.08 | 0.001842 | 0.006402 |
GO:0047793 | cycloeucalenol cycloisomerase activity | 1.39% (1/72) | 9.08 | 0.001842 | 0.006402 |
GO:0016105 | triterpenoid catabolic process | 2.78% (2/72) | 5.0 | 0.001807 | 0.006405 |
GO:0019741 | pentacyclic triterpenoid catabolic process | 2.78% (2/72) | 5.0 | 0.001807 | 0.006405 |
GO:1902381 | 11-oxo-beta-amyrin metabolic process | 2.78% (2/72) | 5.0 | 0.001807 | 0.006405 |
GO:1902382 | 11-oxo-beta-amyrin catabolic process | 2.78% (2/72) | 5.0 | 0.001807 | 0.006405 |
GO:1902384 | glycyrrhetinate metabolic process | 2.78% (2/72) | 5.0 | 0.001807 | 0.006405 |
GO:1902386 | glycyrrhetinate biosynthetic process | 2.78% (2/72) | 5.0 | 0.001807 | 0.006405 |
GO:0065007 | biological regulation | 54.17% (39/72) | 0.56 | 0.001857 | 0.006438 |
GO:0060612 | adipose tissue development | 2.78% (2/72) | 4.96 | 0.001914 | 0.006603 |
GO:0050595 | 7-deoxyloganin 7-hydroxylase activity | 2.78% (2/72) | 4.96 | 0.001914 | 0.006603 |
GO:0061448 | connective tissue development | 2.78% (2/72) | 4.91 | 0.002024 | 0.006916 |
GO:0050616 | secologanin synthase activity | 2.78% (2/72) | 4.91 | 0.002024 | 0.006916 |
GO:0000166 | nucleotide binding | 22.22% (16/72) | 1.13 | 0.002019 | 0.006932 |
GO:1901265 | nucleoside phosphate binding | 22.22% (16/72) | 1.13 | 0.002019 | 0.006932 |
GO:0051287 | NAD binding | 4.17% (3/72) | 3.57 | 0.002105 | 0.007175 |
GO:0032787 | monocarboxylic acid metabolic process | 12.5% (9/72) | 1.66 | 0.00214 | 0.00719 |
GO:0010611 | regulation of cardiac muscle hypertrophy | 2.78% (2/72) | 4.88 | 0.002137 | 0.007198 |
GO:0010893 | positive regulation of steroid biosynthetic process | 2.78% (2/72) | 4.88 | 0.002137 | 0.007198 |
GO:0014743 | regulation of muscle hypertrophy | 2.78% (2/72) | 4.88 | 0.002137 | 0.007198 |
GO:0045940 | positive regulation of steroid metabolic process | 2.78% (2/72) | 4.88 | 0.002137 | 0.007198 |
GO:0060420 | regulation of heart growth | 2.78% (2/72) | 4.88 | 0.002137 | 0.007198 |
GO:1901652 | response to peptide | 5.56% (4/72) | 2.85 | 0.002351 | 0.007878 |
GO:0018958 | phenol-containing compound metabolic process | 5.56% (4/72) | 2.85 | 0.002379 | 0.007954 |
GO:0046890 | regulation of lipid biosynthetic process | 6.94% (5/72) | 2.43 | 0.002426 | 0.008091 |
GO:0009110 | vitamin biosynthetic process | 4.17% (3/72) | 3.49 | 0.002473 | 0.008229 |
GO:0030324 | lung development | 2.78% (2/72) | 4.76 | 0.002494 | 0.008281 |
GO:0046189 | phenol-containing compound biosynthetic process | 4.17% (3/72) | 3.47 | 0.002571 | 0.008494 |
GO:0043168 | anion binding | 19.44% (14/72) | 1.2 | 0.00257 | 0.008512 |
GO:0009056 | catabolic process | 19.44% (14/72) | 1.19 | 0.002716 | 0.008955 |
GO:0005759 | mitochondrial matrix | 5.56% (4/72) | 2.78 | 0.0028 | 0.009208 |
GO:0043502 | regulation of muscle adaptation | 2.78% (2/72) | 4.66 | 0.002877 | 0.009442 |
GO:1900992 | (-)-secologanin metabolic process | 2.78% (2/72) | 4.63 | 0.003011 | 0.009834 |
GO:1900994 | (-)-secologanin biosynthetic process | 2.78% (2/72) | 4.63 | 0.003011 | 0.009834 |
GO:0042446 | hormone biosynthetic process | 5.56% (4/72) | 2.74 | 0.00313 | 0.010199 |
GO:1901336 | lactone biosynthetic process | 2.78% (2/72) | 4.59 | 0.003147 | 0.010208 |
GO:0052640 | salicylic acid glucosyltransferase (glucoside-forming) activity | 2.78% (2/72) | 4.59 | 0.003147 | 0.010208 |
GO:0005488 | binding | 66.67% (48/72) | 0.41 | 0.003235 | 0.010471 |
GO:0046700 | heterocycle catabolic process | 6.94% (5/72) | 2.32 | 0.003309 | 0.010684 |
GO:0008106 | alcohol dehydrogenase (NADP+) activity | 2.78% (2/72) | 4.53 | 0.003428 | 0.011044 |
GO:0000246 | delta24(24-1) sterol reductase activity | 1.39% (1/72) | 8.08 | 0.003681 | 0.01149 |
GO:0031639 | plasminogen activation | 1.39% (1/72) | 8.08 | 0.003681 | 0.01149 |
GO:0033489 | cholesterol biosynthetic process via desmosterol | 1.39% (1/72) | 8.08 | 0.003681 | 0.01149 |
GO:0042605 | peptide antigen binding | 1.39% (1/72) | 8.08 | 0.003681 | 0.01149 |
GO:0050614 | delta24-sterol reductase activity | 1.39% (1/72) | 8.08 | 0.003681 | 0.01149 |
GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity | 1.39% (1/72) | 8.08 | 0.003681 | 0.01149 |
GO:0102175 | 3-beta-hydroxysteroid dehydrogenase/C4-decarboxylase activity | 1.39% (1/72) | 8.08 | 0.003681 | 0.01149 |
GO:0102191 | 4alpha-carboxy-5alpha-cholesta-7,24-dien-3beta-ol dehydrogenase/C4-decarboxylase activity | 1.39% (1/72) | 8.08 | 0.003681 | 0.01149 |
GO:0004452 | isopentenyl-diphosphate delta-isomerase activity | 1.39% (1/72) | 8.08 | 0.003681 | 0.01149 |
GO:0009918 | sterol delta7 reductase activity | 1.39% (1/72) | 8.08 | 0.003681 | 0.01149 |
GO:0030223 | neutrophil differentiation | 1.39% (1/72) | 8.08 | 0.003681 | 0.01149 |
GO:0004163 | diphosphomevalonate decarboxylase activity | 1.39% (1/72) | 8.08 | 0.003681 | 0.01149 |
GO:1901806 | beta-glucoside biosynthetic process | 2.78% (2/72) | 4.47 | 0.003721 | 0.011538 |
GO:0016109 | tetraterpenoid biosynthetic process | 2.78% (2/72) | 4.47 | 0.003721 | 0.011538 |
GO:0016117 | carotenoid biosynthetic process | 2.78% (2/72) | 4.47 | 0.003721 | 0.011538 |
GO:0044248 | cellular catabolic process | 16.67% (12/72) | 1.27 | 0.003621 | 0.011638 |
GO:0000904 | cell morphogenesis involved in differentiation | 9.72% (7/72) | 1.82 | 0.003641 | 0.011677 |
GO:0080046 | quercetin 4'-O-glucosyltransferase activity | 2.78% (2/72) | 4.41 | 0.004024 | 0.012452 |
GO:0016098 | monoterpenoid metabolic process | 4.17% (3/72) | 3.23 | 0.004062 | 0.012515 |
GO:0016099 | monoterpenoid biosynthetic process | 4.17% (3/72) | 3.23 | 0.004062 | 0.012515 |
GO:1905392 | plant organ morphogenesis | 8.33% (6/72) | 1.98 | 0.00414 | 0.012728 |
GO:0042178 | xenobiotic catabolic process | 2.78% (2/72) | 4.36 | 0.004339 | 0.013281 |
GO:0051153 | regulation of striated muscle cell differentiation | 2.78% (2/72) | 4.36 | 0.004339 | 0.013281 |
GO:0030258 | lipid modification | 4.17% (3/72) | 3.19 | 0.004398 | 0.013432 |
GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor | 2.78% (2/72) | 4.33 | 0.004501 | 0.013715 |
GO:0008395 | steroid hydroxylase activity | 2.78% (2/72) | 4.3 | 0.004665 | 0.014186 |
GO:0016651 | oxidoreductase activity, acting on NAD(P)H | 4.17% (3/72) | 3.15 | 0.00475 | 0.014414 |
GO:0010294 | abscisic acid glucosyltransferase activity | 2.78% (2/72) | 4.28 | 0.004832 | 0.01463 |
GO:0097708 | intracellular vesicle | 13.89% (10/72) | 1.37 | 0.004962 | 0.014993 |
GO:0009820 | alkaloid metabolic process | 6.94% (5/72) | 2.18 | 0.005038 | 0.01519 |
GO:0042987 | amyloid precursor protein catabolic process | 1.39% (1/72) | 7.5 | 0.005516 | 0.015504 |
GO:0047012 | sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity | 1.39% (1/72) | 7.5 | 0.005516 | 0.015504 |
GO:0010685 | tetracyclic triterpenoid metabolic process | 1.39% (1/72) | 7.5 | 0.005516 | 0.015504 |
GO:0010686 | tetracyclic triterpenoid biosynthetic process | 1.39% (1/72) | 7.5 | 0.005516 | 0.015504 |
GO:0034076 | cucurbitadienol synthase activity | 1.39% (1/72) | 7.5 | 0.005516 | 0.015504 |
GO:0034435 | cholesterol esterification | 1.39% (1/72) | 7.5 | 0.005516 | 0.015504 |
GO:0046952 | ketone body catabolic process | 1.39% (1/72) | 7.5 | 0.005516 | 0.015504 |
GO:0072019 | proximal convoluted tubule development | 1.39% (1/72) | 7.5 | 0.005516 | 0.015504 |
GO:0072170 | metanephric tubule development | 1.39% (1/72) | 7.5 | 0.005516 | 0.015504 |
GO:0072207 | metanephric epithelium development | 1.39% (1/72) | 7.5 | 0.005516 | 0.015504 |
GO:0072229 | metanephric proximal convoluted tubule development | 1.39% (1/72) | 7.5 | 0.005516 | 0.015504 |
GO:0072234 | metanephric nephron tubule development | 1.39% (1/72) | 7.5 | 0.005516 | 0.015504 |
GO:0072243 | metanephric nephron epithelium development | 1.39% (1/72) | 7.5 | 0.005516 | 0.015504 |
GO:0120225 | coenzyme A binding | 1.39% (1/72) | 7.5 | 0.005516 | 0.015504 |
GO:1902860 | propionyl-CoA biosynthetic process | 1.39% (1/72) | 7.5 | 0.005516 | 0.015504 |
GO:0050992 | dimethylallyl diphosphate biosynthetic process | 1.39% (1/72) | 7.5 | 0.005516 | 0.015504 |
GO:0004631 | phosphomevalonate kinase activity | 1.39% (1/72) | 7.5 | 0.005516 | 0.015504 |
GO:0004421 | hydroxymethylglutaryl-CoA synthase activity | 1.39% (1/72) | 7.5 | 0.005516 | 0.015504 |
GO:0034014 | response to triglyceride | 1.39% (1/72) | 7.5 | 0.005516 | 0.015504 |
GO:0034696 | response to prostaglandin F | 1.39% (1/72) | 7.5 | 0.005516 | 0.015504 |
GO:0046690 | response to tellurium ion | 1.39% (1/72) | 7.5 | 0.005516 | 0.015504 |
GO:0055094 | response to lipoprotein particle | 1.39% (1/72) | 7.5 | 0.005516 | 0.015504 |
GO:0070543 | response to linoleic acid | 1.39% (1/72) | 7.5 | 0.005516 | 0.015504 |
GO:0071404 | cellular response to low-density lipoprotein particle stimulus | 1.39% (1/72) | 7.5 | 0.005516 | 0.015504 |
GO:0070087 | chromo shadow domain binding | 1.39% (1/72) | 7.5 | 0.005516 | 0.015504 |
GO:0003867 | 4-aminobutyrate transaminase activity | 1.39% (1/72) | 7.5 | 0.005516 | 0.015504 |
GO:0009447 | putrescine catabolic process | 1.39% (1/72) | 7.5 | 0.005516 | 0.015504 |
GO:0034387 | 4-aminobutyrate:pyruvate transaminase activity | 1.39% (1/72) | 7.5 | 0.005516 | 0.015504 |
GO:0045303 | diaminobutyrate-2-oxoglutarate transaminase activity | 1.39% (1/72) | 7.5 | 0.005516 | 0.015504 |
GO:0102351 | gamma-aminobutyrate transaminase (glyoxylate dependent) activity | 1.39% (1/72) | 7.5 | 0.005516 | 0.015504 |
GO:0071916 | dipeptide transmembrane transporter activity | 2.78% (2/72) | 4.18 | 0.005527 | 0.015505 |
GO:1902932 | positive regulation of alcohol biosynthetic process | 2.78% (2/72) | 4.23 | 0.005174 | 0.015567 |
GO:0009790 | embryo development | 11.11% (8/72) | 1.56 | 0.005641 | 0.015793 |
GO:0072329 | monocarboxylic acid catabolic process | 4.17% (3/72) | 3.06 | 0.005664 | 0.015825 |
GO:0042592 | homeostatic process | 13.89% (10/72) | 1.34 | 0.00571 | 0.015923 |
GO:1904813 | ficolin-1-rich granule lumen | 2.78% (2/72) | 4.2 | 0.005349 | 0.016025 |
GO:0033383 | geranyl diphosphate metabolic process | 2.78% (2/72) | 4.2 | 0.005349 | 0.016025 |
GO:0005215 | transporter activity | 12.5% (9/72) | 1.45 | 0.005361 | 0.016026 |
GO:0042537 | benzene-containing compound metabolic process | 5.56% (4/72) | 2.48 | 0.005837 | 0.016245 |
GO:0051147 | regulation of muscle cell differentiation | 2.78% (2/72) | 4.11 | 0.006077 | 0.016879 |
GO:0006811 | ion transport | 11.11% (8/72) | 1.54 | 0.006105 | 0.016924 |
GO:0042182 | ketone catabolic process | 2.78% (2/72) | 4.08 | 0.006266 | 0.017335 |
GO:0048638 | regulation of developmental growth | 9.72% (7/72) | 1.67 | 0.006461 | 0.01784 |
GO:0010268 | brassinosteroid homeostasis | 2.78% (2/72) | 4.02 | 0.006847 | 0.01887 |
GO:0051716 | cellular response to stimulus | 26.39% (19/72) | 0.84 | 0.007 | 0.019253 |
GO:0004310 | farnesyl-diphosphate farnesyltransferase activity | 1.39% (1/72) | 7.08 | 0.007348 | 0.019343 |
GO:0051996 | squalene synthase activity | 1.39% (1/72) | 7.08 | 0.007348 | 0.019343 |
GO:0042982 | amyloid precursor protein metabolic process | 1.39% (1/72) | 7.08 | 0.007348 | 0.019343 |
GO:0016871 | cycloartenol synthase activity | 1.39% (1/72) | 7.08 | 0.007348 | 0.019343 |
GO:0010894 | negative regulation of steroid biosynthetic process | 1.39% (1/72) | 7.08 | 0.007348 | 0.019343 |
GO:0045541 | negative regulation of cholesterol biosynthetic process | 1.39% (1/72) | 7.08 | 0.007348 | 0.019343 |
GO:0090206 | negative regulation of cholesterol metabolic process | 1.39% (1/72) | 7.08 | 0.007348 | 0.019343 |
GO:0106119 | negative regulation of sterol biosynthetic process | 1.39% (1/72) | 7.08 | 0.007348 | 0.019343 |
GO:0008830 | dTDP-4-dehydrorhamnose 3,5-epimerase activity | 1.39% (1/72) | 7.08 | 0.007348 | 0.019343 |
GO:0008831 | dTDP-4-dehydrorhamnose reductase activity | 1.39% (1/72) | 7.08 | 0.007348 | 0.019343 |
GO:0010253 | UDP-rhamnose biosynthetic process | 1.39% (1/72) | 7.08 | 0.007348 | 0.019343 |
GO:0010280 | UDP-L-rhamnose synthase activity | 1.39% (1/72) | 7.08 | 0.007348 | 0.019343 |
GO:0010489 | UDP-4-keto-6-deoxy-glucose-3,5-epimerase activity | 1.39% (1/72) | 7.08 | 0.007348 | 0.019343 |
GO:0010490 | UDP-4-keto-rhamnose-4-keto-reductase activity | 1.39% (1/72) | 7.08 | 0.007348 | 0.019343 |
GO:0033478 | UDP-rhamnose metabolic process | 1.39% (1/72) | 7.08 | 0.007348 | 0.019343 |
GO:0050377 | UDP-glucose 4,6-dehydratase activity | 1.39% (1/72) | 7.08 | 0.007348 | 0.019343 |
GO:0071402 | cellular response to lipoprotein particle stimulus | 1.39% (1/72) | 7.08 | 0.007348 | 0.019343 |
GO:0052748 | baicalin beta-D-glucuronidase activity | 1.39% (1/72) | 7.08 | 0.007348 | 0.019343 |
GO:0004015 | adenosylmethionine-8-amino-7-oxononanoate transaminase activity | 1.39% (1/72) | 7.08 | 0.007348 | 0.019343 |
GO:0042400 | ectoine catabolic process | 1.39% (1/72) | 7.08 | 0.007348 | 0.019343 |
GO:0051055 | negative regulation of lipid biosynthetic process | 2.78% (2/72) | 3.96 | 0.007453 | 0.019473 |
GO:0046184 | aldehyde biosynthetic process | 2.78% (2/72) | 3.96 | 0.007453 | 0.019473 |
GO:0016108 | tetraterpenoid metabolic process | 2.78% (2/72) | 3.96 | 0.007453 | 0.019473 |
GO:0016116 | carotenoid metabolic process | 2.78% (2/72) | 3.96 | 0.007453 | 0.019473 |
GO:0010033 | response to organic substance | 30.56% (22/72) | 0.75 | 0.007467 | 0.019476 |
GO:0043604 | amide biosynthetic process | 6.94% (5/72) | 2.04 | 0.007514 | 0.019562 |
GO:0004033 | aldo-keto reductase (NADP) activity | 2.78% (2/72) | 3.98 | 0.007248 | 0.019897 |
GO:0019216 | regulation of lipid metabolic process | 6.94% (5/72) | 2.05 | 0.007285 | 0.01992 |
GO:0048878 | chemical homeostasis | 12.5% (9/72) | 1.38 | 0.007279 | 0.019943 |
GO:1901804 | beta-glucoside metabolic process | 2.78% (2/72) | 3.88 | 0.008296 | 0.021517 |
GO:0007283 | spermatogenesis | 4.17% (3/72) | 2.86 | 0.008283 | 0.021523 |
GO:0031983 | vesicle lumen | 2.78% (2/72) | 3.86 | 0.008513 | 0.021959 |
GO:0034774 | secretory granule lumen | 2.78% (2/72) | 3.86 | 0.008513 | 0.021959 |
GO:0060205 | cytoplasmic vesicle lumen | 2.78% (2/72) | 3.86 | 0.008513 | 0.021959 |
GO:0016746 | acyltransferase activity | 6.94% (5/72) | 1.98 | 0.008895 | 0.022903 |
GO:0005775 | vacuolar lumen | 2.78% (2/72) | 3.82 | 0.008955 | 0.023016 |
GO:0060282 | positive regulation of oocyte development | 1.39% (1/72) | 6.76 | 0.009177 | 0.023163 |
GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process | 1.39% (1/72) | 6.76 | 0.009177 | 0.023163 |
GO:0003985 | acetyl-CoA C-acetyltransferase activity | 1.39% (1/72) | 6.76 | 0.009177 | 0.023163 |
GO:0016453 | C-acetyltransferase activity | 1.39% (1/72) | 6.76 | 0.009177 | 0.023163 |
GO:0046356 | acetyl-CoA catabolic process | 1.39% (1/72) | 6.76 | 0.009177 | 0.023163 |
GO:0045939 | negative regulation of steroid metabolic process | 1.39% (1/72) | 6.76 | 0.009177 | 0.023163 |
GO:0050993 | dimethylallyl diphosphate metabolic process | 1.39% (1/72) | 6.76 | 0.009177 | 0.023163 |
GO:0010731 | protein glutathionylation | 1.39% (1/72) | 6.76 | 0.009177 | 0.023163 |
GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity | 1.39% (1/72) | 6.76 | 0.009177 | 0.023163 |
GO:0004566 | beta-glucuronidase activity | 1.39% (1/72) | 6.76 | 0.009177 | 0.023163 |
GO:0031982 | vesicle | 13.89% (10/72) | 1.24 | 0.009411 | 0.023669 |
GO:0042937 | tripeptide transmembrane transporter activity | 2.78% (2/72) | 3.78 | 0.009407 | 0.023703 |
GO:0019439 | aromatic compound catabolic process | 6.94% (5/72) | 1.95 | 0.009537 | 0.023946 |
GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water | 2.78% (2/72) | 3.76 | 0.009637 | 0.024152 |
GO:1901700 | response to oxygen-containing compound | 27.78% (20/72) | 0.77 | 0.009848 | 0.024638 |
GO:1900221 | regulation of amyloid-beta clearance | 1.39% (1/72) | 6.5 | 0.011002 | 0.026951 |
GO:0030539 | male genitalia development | 1.39% (1/72) | 6.5 | 0.011002 | 0.026951 |
GO:1902131 | (+)-lariciresinol catabolic process | 1.39% (1/72) | 6.5 | 0.011002 | 0.026951 |
GO:1902136 | (-)-secoisolariciresinol metabolic process | 1.39% (1/72) | 6.5 | 0.011002 | 0.026951 |
GO:1902138 | (-)-secoisolariciresinol biosynthetic process | 1.39% (1/72) | 6.5 | 0.011002 | 0.026951 |
GO:1902858 | propionyl-CoA metabolic process | 1.39% (1/72) | 6.5 | 0.011002 | 0.026951 |
GO:1902931 | negative regulation of alcohol biosynthetic process | 1.39% (1/72) | 6.5 | 0.011002 | 0.026951 |
GO:0008653 | lipopolysaccharide metabolic process | 1.39% (1/72) | 6.5 | 0.011002 | 0.026951 |
GO:0009103 | lipopolysaccharide biosynthetic process | 1.39% (1/72) | 6.5 | 0.011002 | 0.026951 |
GO:0046951 | ketone body biosynthetic process | 1.39% (1/72) | 6.5 | 0.011002 | 0.026951 |
GO:0042399 | ectoine metabolic process | 1.39% (1/72) | 6.5 | 0.011002 | 0.026951 |
GO:0004774 | succinate-CoA ligase activity | 1.39% (1/72) | 6.5 | 0.011002 | 0.026951 |
GO:0042939 | tripeptide transport | 2.78% (2/72) | 3.66 | 0.011068 | 0.027065 |
GO:0045833 | negative regulation of lipid metabolic process | 2.78% (2/72) | 3.64 | 0.011315 | 0.027621 |
GO:0016860 | intramolecular oxidoreductase activity | 2.78% (2/72) | 3.63 | 0.011564 | 0.028182 |
GO:0009690 | cytokinin metabolic process | 4.17% (3/72) | 2.68 | 0.011632 | 0.028297 |
GO:0048232 | male gamete generation | 4.17% (3/72) | 2.67 | 0.011879 | 0.028849 |
GO:0005996 | monosaccharide metabolic process | 4.17% (3/72) | 2.66 | 0.012004 | 0.029052 |
GO:0009308 | amine metabolic process | 5.56% (4/72) | 2.18 | 0.011983 | 0.029052 |
GO:0022857 | transmembrane transporter activity | 11.11% (8/72) | 1.36 | 0.01238 | 0.029912 |
GO:0044752 | response to human chorionic gonadotropin | 1.39% (1/72) | 6.28 | 0.012824 | 0.030617 |
GO:0061458 | reproductive system development | 1.39% (1/72) | 6.28 | 0.012824 | 0.030617 |
GO:0003988 | acetyl-CoA C-acyltransferase activity | 1.39% (1/72) | 6.28 | 0.012824 | 0.030617 |
GO:0006550 | isoleucine catabolic process | 1.39% (1/72) | 6.28 | 0.012824 | 0.030617 |
GO:0070404 | NADH binding | 1.39% (1/72) | 6.28 | 0.012824 | 0.030617 |
GO:0034694 | response to prostaglandin | 1.39% (1/72) | 6.28 | 0.012824 | 0.030617 |
GO:0005640 | nuclear outer membrane | 1.39% (1/72) | 6.28 | 0.012824 | 0.030617 |
GO:0045229 | external encapsulating structure organization | 9.72% (7/72) | 1.46 | 0.013468 | 0.032101 |
GO:0009628 | response to abiotic stimulus | 30.56% (22/72) | 0.67 | 0.013709 | 0.032619 |
GO:0047037 | salutaridine reductase (NADPH) activity | 1.39% (1/72) | 6.08 | 0.014643 | 0.034377 |
GO:0052581 | (-)-isopiperitenone reductase activity | 1.39% (1/72) | 6.08 | 0.014643 | 0.034377 |
GO:1902438 | response to vanadate(3-) | 1.39% (1/72) | 6.08 | 0.014643 | 0.034377 |
GO:0034433 | steroid esterification | 1.39% (1/72) | 6.08 | 0.014643 | 0.034377 |
GO:0034434 | sterol esterification | 1.39% (1/72) | 6.08 | 0.014643 | 0.034377 |
GO:0035634 | response to stilbenoid | 1.39% (1/72) | 6.08 | 0.014643 | 0.034377 |
GO:0071372 | cellular response to follicle-stimulating hormone stimulus | 1.39% (1/72) | 6.08 | 0.014643 | 0.034377 |
GO:0005637 | nuclear inner membrane | 1.39% (1/72) | 6.08 | 0.014643 | 0.034377 |
GO:0010214 | seed coat development | 4.17% (3/72) | 2.54 | 0.015081 | 0.035347 |
GO:0090257 | regulation of muscle system process | 2.78% (2/72) | 3.38 | 0.015878 | 0.037153 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 6.94% (5/72) | 1.76 | 0.016097 | 0.037605 |
GO:0033869 | nucleoside bisphosphate catabolic process | 1.39% (1/72) | 5.91 | 0.016458 | 0.038069 |
GO:0034031 | ribonucleoside bisphosphate catabolic process | 1.39% (1/72) | 5.91 | 0.016458 | 0.038069 |
GO:0034034 | purine nucleoside bisphosphate catabolic process | 1.39% (1/72) | 5.91 | 0.016458 | 0.038069 |
GO:1900000 | regulation of anthocyanin catabolic process | 1.39% (1/72) | 5.91 | 0.016458 | 0.038069 |
GO:0051777 | ent-kaurenoate oxidase activity | 1.39% (1/72) | 5.91 | 0.016458 | 0.038069 |
GO:0009698 | phenylpropanoid metabolic process | 8.33% (6/72) | 1.56 | 0.016384 | 0.038212 |
GO:0009636 | response to toxic substance | 4.17% (3/72) | 2.48 | 0.016696 | 0.038556 |
GO:0043207 | response to external biotic stimulus | 26.39% (19/72) | 0.72 | 0.016752 | 0.03856 |
GO:0046364 | monosaccharide biosynthetic process | 2.78% (2/72) | 3.34 | 0.016752 | 0.038623 |
GO:0016706 | 2-oxoglutarate-dependent dioxygenase activity | 4.17% (3/72) | 2.48 | 0.016847 | 0.038716 |
GO:1901575 | organic substance catabolic process | 15.28% (11/72) | 1.04 | 0.017026 | 0.039062 |
GO:0032868 | response to insulin | 2.78% (2/72) | 3.3 | 0.017647 | 0.040421 |
GO:0060281 | regulation of oocyte development | 1.39% (1/72) | 5.76 | 0.01827 | 0.041313 |
GO:1904277 | negative regulation of wax biosynthetic process | 1.39% (1/72) | 5.76 | 0.01827 | 0.041313 |
GO:0031638 | zymogen activation | 1.39% (1/72) | 5.76 | 0.01827 | 0.041313 |
GO:0050654 | chondroitin sulfate proteoglycan metabolic process | 1.39% (1/72) | 5.76 | 0.01827 | 0.041313 |
GO:1901569 | fatty acid derivative catabolic process | 1.39% (1/72) | 5.76 | 0.01827 | 0.041313 |
GO:0033760 | 2'-deoxymugineic-acid 2'-dioxygenase activity | 1.39% (1/72) | 5.76 | 0.01827 | 0.041313 |
GO:0043235 | receptor complex | 1.39% (1/72) | 5.76 | 0.01827 | 0.041313 |
GO:0043878 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity | 1.39% (1/72) | 5.76 | 0.01827 | 0.041313 |
GO:0042181 | ketone biosynthetic process | 2.78% (2/72) | 3.25 | 0.018871 | 0.042602 |
GO:0042594 | response to starvation | 6.94% (5/72) | 1.69 | 0.019438 | 0.043813 |
GO:0009607 | response to biotic stimulus | 26.39% (19/72) | 0.7 | 0.019754 | 0.044455 |
GO:1905879 | regulation of oogenesis | 1.39% (1/72) | 5.63 | 0.020079 | 0.044757 |
GO:0008460 | dTDP-glucose 4,6-dehydratase activity | 1.39% (1/72) | 5.63 | 0.020079 | 0.044757 |
GO:0019305 | dTDP-rhamnose biosynthetic process | 1.39% (1/72) | 5.63 | 0.020079 | 0.044757 |
GO:0046383 | dTDP-rhamnose metabolic process | 1.39% (1/72) | 5.63 | 0.020079 | 0.044757 |
GO:0007494 | midgut development | 1.39% (1/72) | 5.63 | 0.020079 | 0.044757 |
GO:0071397 | cellular response to cholesterol | 1.39% (1/72) | 5.63 | 0.020079 | 0.044757 |
GO:0016829 | lyase activity | 6.94% (5/72) | 1.67 | 0.020707 | 0.046085 |
GO:0030176 | integral component of endoplasmic reticulum membrane | 2.78% (2/72) | 3.17 | 0.021096 | 0.046875 |
GO:0003823 | antigen binding | 1.39% (1/72) | 5.5 | 0.021884 | 0.048098 |
GO:0000250 | lanosterol synthase activity | 1.39% (1/72) | 5.5 | 0.021884 | 0.048098 |
GO:0042299 | lupeol synthase activity | 1.39% (1/72) | 5.5 | 0.021884 | 0.048098 |
GO:0032354 | response to follicle-stimulating hormone | 1.39% (1/72) | 5.5 | 0.021884 | 0.048098 |
GO:0071371 | cellular response to gonadotropin stimulus | 1.39% (1/72) | 5.5 | 0.021884 | 0.048098 |
GO:0009448 | gamma-aminobutyric acid metabolic process | 1.39% (1/72) | 5.5 | 0.021884 | 0.048098 |
GO:0046620 | regulation of organ growth | 2.78% (2/72) | 3.14 | 0.02175 | 0.048255 |